What Insulin is
Insulin is an endogenous peptide hormone and an approved medicine class central to glucose regulation.
Insulin is grouped under Endogenous / Biology / Approved / Clinical on PeptideFactCheck because it anchors peptide biology and illustrates how a peptide can be both endogenous and a tightly regulated drug.
The useful starting point is to separate the molecule itself from the internet story around it. It is the reference example for peptide hormones as real medicines.
Why people keep looking it up
People know insulin as the peptide hormone that controls blood sugar.
Insulin signals cells and tissues to handle glucose and coordinate metabolic storage.
Insulin tends to stay in the conversation because it touches a familiar public theme: insulin receptor, glucose uptake, and metabolic signaling. That makes it easy for the claim to travel faster than the evidence.
What the evidence can support right now
It is a tightly regulated, high-risk approved medicine class. PeptideFactCheck does not provide use instructions.
Extensive human clinical evidence and official labeling exist across insulin products.
Core mechanism is well established through receptor signaling and metabolic physiology.
Why this page carries the current tier: Established peptide hormone and approved medicine class.
The current seed trail for Insulin is pulling from 1 labels source, 1 regulatory source, and 1 literature source.
Safety, limits, and regulatory context
Insulin can be high risk when misused. PeptideFactCheck does not provide administration or dosing instructions.
Multiple FDA-approved insulin products exist with official labeling.
Editorial boundary: PeptideFactCheck does not publish dosing, cycling, sourcing, injection, or administration instructions for Insulin. The job here is to explain the public claim, the mechanism story, the evidence strength, and the current limits.
Molecular and identifier data
The current PubChem match for Insulin is CID 70678557. That gives the page a source-backed chemistry record rather than a placeholder identifier block.
- PubChem CID
- 70678557
- Formula
- C256H381N65O77S6
- Molecular weight
- 5794
- InChIKey
- YAJCHEVQCOHZDC-QMMNLEPNSA-N
Matched synonyms include 9004-10-8, Endopancrine, Decurvon, Dermulin, Insular, Insulyl, Iszilin, Musulin.
Open PubChem recordClinical trial snapshot
The current ClinicalTrials.gov intervention query for Insulin returns 7981 study records. This does not prove efficacy by itself, but it does show whether the peptide is showing up in a formal trial registry rather than only in forums or vendor copy.
Literature snapshot
The current PubMed query for Insulin returns 513923 results. The articles below are a quick literature surface so the page shows actual papers instead of only generic evidence labels.
Label and regulatory records
For approved or clinically developed peptides, the page now pulls in official labeling and FDA-facing records where they exist. That makes the regulatory section materially more useful than a generic approved or not-approved tag.
- Brand names
- DNA Pancreas Formula
- Generic names
- LYCOPODIUM CLAVATUM, PANCREAS SUIS, DNA, INSULINUM (HUMAN), PHOSPHORICUM ACIDUM, RADIUM BROMATUM, URANIUM NITRICUM
- Routes
- ORAL
- Application numbers
- Not linked
Indications and usage. USES: Assists in support of the pancreas.† †Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.
Source trail
Each linked source is shown directly so the page can be audited. The page now combines its editorial seed trail with automated official-source enrichment generated on 2026-04-24 from PubChem, ClinicalTrials.gov, PubMed, DailyMed, openFDA label, and Drugs@FDA.